BCR-ABL
The firm's new application of its BCR-ABL test will be able to detect p190 transcripts and is currently for research use only.
At AACR, Stanford Team Shares Single-Cell Fusion Detection Tool For Mapping Tumor Cells
The SICILIAN algorithm, which uses statistical modeling to score candidate fusions in single-cell RNA sequencing data, is being used to map splice sites in individual tumor cells.
Cepheid Xpert BCR-ABL Ultra Leukemia Monitoring Test Gets FDA Clearance
The in vitro diagnostic test can deliver molecular results from whole blood samples in less than three hours, the company said.
Health Canada Approves Two BCR-ABL Tests
The tests from Asuragen and MolecularMD are designed for use in chronic myeloid leukemia patients, including those receiving tyrosine kinase inhibitor therapy.
MolecularMD, Genoptix Ink Marketing Agreement for CDx to Novartis CML Drug
The companion diagnostic test identifies patients taking the Novartis drug Tasigna who are candidates for treatment-free remission monitoring.
Jul 25, 2016
Asuragen BCR-ABL Kit Granted FDA Premarket Clearance
Jun 11, 2015
Asuragen BCR-ABL Assay Receives CE Mark
Jan 17, 2013
Sep 5, 2012
Jun 2, 2011
Dec 15, 2010
New Releases: Dec 15, 2010
Premium
Dec 9, 2010